Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
Information source: Emory University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Influenza
Intervention: Arm 1 and Arm 2: Inactivated Flu Vaccine (Drug); Metronidazole (Drug); Neomycin (Drug); Vancomycin (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Emory University Official(s) and/or principal investigator(s): Nadine Rouphael, MD, Principal Investigator, Affiliation: Emory University
Summary
The purpose of the study is to better understand how the use of antibiotics changes
micro-organisms in the intestines. The change to micro-organisms in the intestines may
change the body's vaccine immune response and alter the effectiveness of the IIV (seasonal
flu) vaccine.
In particular, the investigators will be looking at certain markers in blood after
vaccination with IIV (seasonal flu vaccine) with or without the use of antibiotics before
vaccination.
There will be two randomized groups. Group A will start taking antibiotic by mouth 3 days
prior to vaccination and continue taking antibiotics the day of vaccination and one day
after vaccination for a total of 5 days. Group B will only receive the IIV (seasonal flu
vaccine) and will not take any antibiotics.
The investigators hope to enroll 22 subjects at Emory.
Clinical Details
Official title: Systems Biology of Inactivated Influenza Vaccine (IIV) in Healthy Adults With or Without Use of Broad Spectrum Antibiotics
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Primary outcome: Number of participants with four fold rise in HAI titers or HAI 1:40 and above in each group at D30
Detailed description:
We will study using a system biology approach the immune responses to IIV alone vs. IIV with
antibiotic administration
Eligibility
Minimum age: 18 Years.
Maximum age: 40 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. Healthy individuals aged 18-40 years.
2. Able to understand and give informed consent.
3. Women of child-bearing potential (not surgically sterile via tubal ligation,
bilateral oophorectomy or hysterectomy or who are not postmenopausal for ≥1 year)
must agree to practice adequate contraception that may include, but is not limited
to, abstinence, monogamous relationship with vasectomized partner, barrier methods
such as condoms, diaphragms, spermicides, intrauterine devices, and licensed hormonal
methods for 30 days before and 30 days after TIV vaccination
Exclusion Criteria:
- You received blood product within 3 months of enrolling in the study or a live
attenuated vaccine within 4 weeks or inactivated vaccines within 2 weeks.
- You received the 2014-2015 flu vaccine or had a confirmed case of influenza during
2014-2015.
- You received any antibiotics 6 months prior to enrolling in the study or expect to
take antibiotics one month after vaccination.
- You received probiotics or prebiotics 3 months prior before enrolling in the study or
expect to take one month after vaccination.
- You received proton pump inhibitors, H2 blocker receptors, or antacids 3 months
regularly before enrolling in the study or one month after
- You had an allergic response or sensitivity to past vaccinations.
- You have health conditions that weaken your body's ability to fight infections or you
are taking drugs like steroids that weaken your body's ability to fight
infections.(Some nasal and topical steroids are allowed.).
- You have a chronic medical problem including (but not limited to) insulin dependent
diabetes, severe heart disease including arrhythmias, severe lung disease, auto
immune diseases and or grade 4 uncontrolled hypertension.
- Chronic neurological conditions such as seizure disorder, Parkinson disease,
myasthenia gravis, neuropathy, or histories of encephalopathy, meningitis or
ototoxicity.
- Any history of gastrointestinal disease, kidney or liver diseases.
- Alcohol or drug abuse or psychiatric conditions that in the opinion of the
investigator would compromise your participation in this trial.
- Pregnant or are breast feeding.
Locations and Contacts
Emory Vaccine Center, Atlanta, Georgia 30030, United States
Additional Information
Starting date: April 2015
Last updated: July 20, 2015
|